deltatrials
Recruiting PHASE3 INTERVENTIONAL 2-arm NCT02484248

Ketotifen for Children With Functional Dyspepsia in Association With Duodenal Eosinophilia (Ketotifen)

Double-blind, Placebo-controlled, Cross-over Trial of Ketotifen in Children and Adolescents With Functional Dyspepsia in Association With Duodenal Eosinophilia

Sponsor: Craig A. Friesen, MD

Conditions Functional Dyspepsia
Interventions Ketotifen Placebo
Updated 15 times since 2017 Last updated: Jan 8, 2026 Started: Aug 31, 2015 Primary completion: Apr 1, 2027 Completion: Apr 1, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02484248, this PHASE3 trial focuses on Functional Dyspepsia and remains actively recruiting participants. Sponsored by Craig A. Friesen, MD, it has been updated 15 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Nov 2020 · 26 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Nov 2021 · 10 months · monthly snapshot~Nov 2021 – ~Nov 2022 · 12 months · monthly snapshot~Nov 2022 – ~Oct 2023 · 11 months · monthly snapshot~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – ~May 2025 · 7 months · monthly snapshot~May 2025 – ~Oct 2025 · 5 months · monthly snapshot~Oct 2025 – ~Feb 2026 · 4 months · monthly snapshot~Feb 2026 – present · 5 months · monthly snapshot

Change History

15 versions recorded

  1. Feb 2026 — Present [monthly]

    Recruiting PHASE3

  2. Oct 2025 — Feb 2026 [monthly]

    Recruiting PHASE3

  3. May 2025 — Oct 2025 [monthly]

    Recruiting PHASE3

    Status: Active Not Recruiting → Recruiting

  4. Oct 2024 — May 2025 [monthly]

    Active Not Recruiting PHASE3

  5. Sep 2024 — Oct 2024 [monthly]

    Active Not Recruiting PHASE3

▶ Show 10 earlier versions

  1. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE3

  2. Oct 2023 — Jul 2024 [monthly]

    Active Not Recruiting PHASE3

    Status: Recruiting → Active Not Recruiting

  3. Nov 2022 — Oct 2023 [monthly]

    Recruiting PHASE3

  4. Nov 2021 — Nov 2022 [monthly]

    Recruiting PHASE3

  5. Jan 2021 — Nov 2021 [monthly]

    Recruiting PHASE3

  6. Nov 2020 — Jan 2021 [monthly]

    Recruiting PHASE3

  7. Sep 2018 — Nov 2020 [monthly]

    Recruiting PHASE3

    Status: Not Yet Recruiting → Recruiting

  8. Jun 2018 — Sep 2018 [monthly]

    Not Yet Recruiting PHASE3

  9. Feb 2017 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE3

  10. Jan 2017 — Feb 2017 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Aug 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Craig A. Friesen, MD
Data source: Children's Mercy Hospital Kansas City

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations